Clinical Pathway Lectures

General Overview Educational Goals

Target Audience Sponsored By

Faculty Disclosures

General Overview Top

The Clinical Pathway was held as part of the 2002 Ryan White CARE Act Grantee Meeting, August 20-21, 2002, in Washington, DC. The Clinical Pathway focuses on current clinical issues in HIV management. This is an archive of the live lectures.


Educational Goals Top

The goal of these online lectures is to provide participants with:

• A comprehensive and timely overview of HIV treatment issues
• Current strategies in HIV management

Target Audience Top

This has been designed for clinicians who provide services and are actively involved in direct HIV/AIDS patient care in Ryan White CARE Act funded clinics


Sponsored By Top

Sponsored By the International AIDS Society-USA and was funded by and conducted in collaboration with the HIV/AIDS Bureau, Health Resources and Services Administration of the U.S. Department of Health and Human Services.


Faculty Members Top

Erika Z. Aaron, CRNP Director of Women's Services Partnership Comprehensive Care Practice Drexel University School of Medicine Philadelphia, Pennsylvania Andrew F. Angelino, MD Assistant Professor The Johns Hopkins University Baltimore, Maryland Constance A. Benson, MD Professor of Medicine University of Colorado Health Sciences Center Denver, Colorado Member, Board of Directors International AIDS Society-USA Thomas C. Quinn, MD Professor of Medicine, International Health, Molecular Microbiology and Immunology The Johns Hopkins University Baltimore, Maryland Paul A. Goepfert, MD Assistant Professor Department of Medicine and Microbiology Director of Translational Research Alabama Vaccine Research Clinic The University of Alabama at Birmingham Birmingham, Alabama Roy M. Gulick, MD, MPH Associate Professor of Medicine Weill Medical College of Cornell University Director, Cornell University HIV Clinical Trials Unit New York Presbyterian Hospital New York, New York Colleen M. Hadigan, MD, MPH Assistant Professor of Pediatrics Harvard Medical School Boston, Massachusetts

Raymond T. Chung, MD Assistant Professor of Medicine Harvard Medical School Director of Hepatology Massachusetts General Hospital Boston, Massachusetts Henry Francis, MD Director, Center on AIDS and Other Medical Consequences of Drug Abuse National Institute on Drug Abuse, National Institutes of Health Bethesda, Maryland Daniel R. Kuritzkes, MD Director of AIDS Research Partners AIDS Research Center Brigham and Women's Hospital Cambridge, Massachusetts Associate Professor of Medicine Harvard Medical School Boston, Massachusetts Henry Masur, MD Chief, Critical Care Medicine Department National Institutes of Health Bethesda, Maryland Meg D. Newman, MD Associate Professor of Medicine University of California San Francisco Director, AIDS Education UCSF Positive Health Program San Francisco, California

Disclosure of Significant Relationships Top

The following faculty members have indicated an affiliation with commercial organizations that have interests related to the content of this program.

Ms Aaron has no affiliations to disclose.

Dr Angelino has served on the speakers' bureau for Agouron, AstraZeneca, Eli Lilly, GlaxoSmithKline, OrthoBiotech, Pfizer, Schering, and Wyeth.

Dr Benson has served as a consultant and scientific advisor to Abbott, Gilead, GlaxoSmithKline, Merck, and Triangle. She has also received grant support from Abbott, Bristol-Myers Squibb, and Triangle.

Dr Cheever has no affiliations to disclose.

Dr Chung has received grant support from Roche and Schering.

Dr Francis has no affiliations to disclose.

Dr Goepfert has received grant and research support from MedImmune and Merck.

Dr Gulick has served as a consultant or scientific advisor to Abbott, Bristol-Myers Squibb, GlaxoSmithKline, Shionogi, and ViroLogic and received speaker honoraria from Merck. He has also received grant and research support from Abbott, Merck, and Trimeris.

Dr Hadigan has no affiliations to disclose.

Dr Kuritzkes has received grant support from Agouron, Bristol-Myers Squibb, GlaxoSmithKline, Roche, Tanox, Trimeris, Triangle, and Visible Genetics and honoraria from Abbott, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Roche, and ViroLogic. He has also served as a consultant to Abbott, Bristol-Myers Squibb, Chiron, Gilead, GlaxoSmithKline, Roche, Trimeris, Triangle, Virco, and ViroLogic.

Dr Masur has no affiliations to disclose.

Dr Newman has received speaker honoraria from Bristol-Myers Squibb, GlaxoSmithKline, and Roche.

Dr Quinn has served on the speakers bureau for Abbott, Agouron, Bristol-Myers Squibb, Hoffmann-La Roche, and Pfizer.

Dr Saag has received grant and research support from Abbott, Agouron, Bristol-Myers Squibb, Dupont Pharma, Gilead, Glaxo-Wellcome, Hoffmann-La Roche, Janssen, Pfizer, Pharmacia & Upjohn, and Triangle. He has also served as a consultant to and on the speakers bureau for Agouron, Biochem Pharma, Bristol-Myers Squibb, Dupont Pharma, Glaxo-Wellcome, Hoffman-La Roche, OrthoBiotech, Pfizer, and Trimeris.